Healthy Weight Management Project for Overweight and Obesity Children
1 other identifier
interventional
331
1 country
1
Brief Summary
Childhood obesity is a significant public health concern worldwide. In China, childhood obesity has dramatically increased as the economy has grown quickly over the past decades. Nonalcoholic fatty liver disease (NAFLD) is tightly associated with obesity, in China, the prevalence of NAFLD in obesity children is 40.0%,the main interventions for NAFLD are lifestyle interventions. Effective strategies to helping students lose weight and alleviate NAFLD through lifestyle interventions may help promote the physical and mental health of obese students. This study aimed (1)to assess the effectiveness of the intervention compared with the usual practice in treating childhood overweight and obesity; (2) to determine the sustainability of the treatment in preventing overweight and obesity; (3) to help alleviate or reverse NAFLD in obesity children. Children with overweight and obesity in six primary schools in Ningbo City, Zhejiang Province will be seleted and randomly divided into two groups: the treatment group and the usual practice group. The participants of the study were students in the third grade of primary school, and the treatment will last for one academic year. This treatment activity on lifestyle interventions will target the dietary and exercise factors of childhood obesity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable obesity
Started Sep 2022
Typical duration for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 28, 2022
CompletedFirst Posted
Study publicly available on registry
August 1, 2022
CompletedStudy Start
First participant enrolled
September 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 25, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedJuly 9, 2025
July 1, 2025
10 months
July 28, 2022
July 4, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
change in body mass index (BMI)
* weight and height will be combined to report BMI in kg/m\^2 * caculated by terminal value minus baseline value
3 months,9 months , 24 months and 36 months
change in controlled attenuation parameters (CAP)
* CAP will be detected by Fibroscan * caculated by terminal value minus baseline value
3 months,9 months , 24 months and 36 months
Change in liver stiffness measurement (LSM)
* LSM will be detected by Fibroscan * caculated by terminal value minus baseline value
3 months,9 months , 24 months and 36 months
Secondary Outcomes (9)
Change in BMI z- score
3 months,9 months , 24 months and 36 months
change in blood glucose
9 months
change in blood lipids
9 months
change in fasting insulin
9 months
change in body fat percentage
3 months and 9 months
- +4 more secondary outcomes
Study Arms (2)
Treatment group
EXPERIMENTALTreatment activity on lifestyle interventions will target the dietary and exercise factors of childhood obesity.
Usual practice group
NO INTERVENTIONNo intervention
Interventions
This intervention programme will target the influencing factors of childhood obesity to influence the knowledge, attitude and behaviours of school children. Students in the treatment group will receive the following interventions: * Develop and implement school policies related to weight loss * Distribute health education materials on diet and exercise to students * Carry out student health education courses * Diet and exercise instruction by professional nutritionist using internet applet * Take part in sports activities that are organized by the sports health teacher during school hours.
Eligibility Criteria
You may qualify if:
- parents agree and support their children's weight loss, and students and parents have informed consent;
- students in third grade aged 8 and 10 years old;
- students with childhood overweight/obesity defined according to the criteria for Chinese children and adolescents.
You may not qualify if:
- medical history of heart disease, hypertension, diabetes, tuberculosis, asthma, hepatitis or nephritis;
- obesity caused by endocrine diseases or side effects of drugs;
- abnormal physical development like dwarfism or gigantism;
- physical deformity such as severe scoliosis, pectus carinatum, limp, obvious O-leg or X-leg;
- inability to participate in school sport activities;
- a loss in weight by vomiting or taking drugs during the past 3 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ningbo No. 1 Hospitallead
- Peking Universitycollaborator
Study Sites (1)
Ningbo First Hospital
Ningbo, China
Related Publications (1)
Zhang PP, Wang YX, Shen FJ, Xing YF, Gu JY, Li XY, Jin H, Jin SF, Xu M, Wang HJ, Wang H, Li L. Lifestyle intervention in children with obesity and nonalcoholic fatty liver disease (NAFLD): study protocol for a randomized controlled trial in Ningbo city (the SCIENT study). Trials. 2024 Mar 20;25(1):196. doi: 10.1186/s13063-024-08046-4.
PMID: 38504343DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 28, 2022
First Posted
August 1, 2022
Study Start
September 1, 2022
Primary Completion
June 25, 2023
Study Completion
December 31, 2025
Last Updated
July 9, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share